Quality control issues have forced medical diagnostics company Alere Inc. to recall 897,000 individual tests used to detect heart attacks and drug use, the company said today in a regulatory filing with the U.S. Securities and Exchange Commission. Alere has begun an additional recall of its Triage meter-based products as a result of “continuing inspection” by the U.S. Food and Drug Administration.
